← Return to Aromatase Inhibitors: Did you decide to go on them or not?

Discussion
Comment receiving replies
@windyshores

I am trying to understand. Oncotype does two things: assesses risk of distant recurrence, and benefit of chemo. So if risk is low wouldn't that help a patient decide not to have radiation>

I think it is different for mastectomy patients, many of whom do not have radiation. This was my biggest decision. I was told that one in five radiologists would suggest radiation for me, and my tumor board said no.. My low Oncotype (and assumed low recurrence risk at that time) definitely affected my decision not to have radiation.

Jump to this post


Replies to "I am trying to understand. Oncotype does two things: assesses risk of distant recurrence, and benefit..."

I can't speak to how people would likely evaluate the OncotypeDX score but it helped me skip "clean-up" radiation because it was too small a risk reduction versus possible side effects. Someone else might say that she wants every conceivable weapon available tossed at the recurrence risk, even just in that one tiny area. My breast surgeon, on the basis of pre- and post-surgical biopsies assumed that radiation wouldn't even be recommended. And the radiologist did offer it as an option, but not an insistent recommendation.